[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (1,610)

Search Parameters:
Keywords = traumatic brain injury

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
10 pages, 666 KiB  
Systematic Review
Long-Term Return to Work After Mild and Moderate Traumatic Brain Injury: A Systematic Literature Review
by Emilia Westarp, Tim Jonas Hallenberger, Karl-Olof Lövblad, Thomas Mokrusch, Claudio Bassetti and Raphael Guzman
Clin. Transl. Neurosci. 2024, 8(4), 31; https://doi.org/10.3390/ctn8040031 - 20 Dec 2024
Abstract
Background: Traumatic brain injury (TBI) is referred to as a “silent epidemic” due to its limited awareness in the general public. Nevertheless, it can cause chronic, lifelong physical and cognitive impairments with severe impact on quality of life, resulting in high healthcare costs [...] Read more.
Background: Traumatic brain injury (TBI) is referred to as a “silent epidemic” due to its limited awareness in the general public. Nevertheless, it can cause chronic, lifelong physical and cognitive impairments with severe impact on quality of life, resulting in high healthcare costs and loss of employment. To evaluate the outcome after mild and moderate TBI, “return to work (RTW)” is a relevant parameter, reflecting the socio-economic consequences of TBI. Our study aims to summarize RTW-rates to raise awareness on the impact of non-severe TBI. Methods: We performed a systematic literature review screening the databases Medline, Embase and Web of Science for studies reporting RTW in mild to moderate TBI. Studies that reported on RTW after mild or moderate TBI (defined by GCS > 9) in adults, with a minimum follow-up of six months were included. Risk of bias was assessed using the QUIPS tool. Results: We included 13 studies with a total 22,550 patients. The overall RTW rate after at least six months, varies between 37% and 98%. Full RTW is reported in six of the included 13 studies and varies between 12% and 67%. In six studies (46%) the RTW-rate by the end of follow-up was ≤60%, with four studies being from high-income countries. Conclusion: Mild and moderate TBI have a high impact on employment rates with diverging rates for RTW even between high-income countries. Increasing the societal awareness of this silent epidemic is of utmost importance and is one of the missions of the Swiss Brain Health Plan. Full article
(This article belongs to the Special Issue Brain Health)
Show Figures

Figure 1

Figure 1
<p>Flow chart for study selection.</p>
Full article ">
21 pages, 807 KiB  
Review
Digital Eye-Movement Outcomes (DEMOs) as Biomarkers for Neurological Conditions: A Narrative Review
by Lisa Graham, Rodrigo Vitorio, Richard Walker, Gill Barry, Alan Godfrey, Rosie Morris and Samuel Stuart
Big Data Cogn. Comput. 2024, 8(12), 198; https://doi.org/10.3390/bdcc8120198 - 19 Dec 2024
Abstract
Eye-movement assessment is a key component of neurological evaluation, offering valuable insights into neural deficits and underlying mechanisms. This narrative review explores the emerging subject of digital eye-movement outcomes (DEMOs) and their potential as sensitive biomarkers for neurological impairment. Eye tracking has become [...] Read more.
Eye-movement assessment is a key component of neurological evaluation, offering valuable insights into neural deficits and underlying mechanisms. This narrative review explores the emerging subject of digital eye-movement outcomes (DEMOs) and their potential as sensitive biomarkers for neurological impairment. Eye tracking has become a useful method for investigating visual system functioning, attentional processes, and cognitive mechanisms. Abnormalities in eye movements, such as altered saccadic patterns or impaired smooth pursuit, can act as important diagnostic indicators for various neurological conditions. The non-invasive nature, cost-effectiveness, and ease of implementation of modern eye-tracking systems makes it particularly attractive in both clinical and research settings. Advanced digital eye-tracking technologies and analytical methods enable precise quantification of eye-movement parameters, complementing subjective clinical evaluations with objective data. This review examines how DEMOs could contribute to the localisation and diagnosis of neural impairments, potentially serving as useful biomarkers. By comprehensively exploring the role of eye-movement assessment, this review aims to highlight the common eye-movement deficits seen in neurological injury and disease by using the examples of mild traumatic brain injury and Parkinson’s Disease. This review also aims to enhance the understanding of the potential use of DEMOs in diagnosis, monitoring, and management of neurological disorders, ultimately improving patient care and deepening our understanding of complex neurological processes. Furthermore, we consider the broader implications of this technology in unravelling the complexities of visual processing, attention mechanisms, and cognitive functions. This review summarises how DEMOs could reshape our understanding of brain health and allow for more targeted and effective neurological interventions. Full article
Show Figures

Figure 1

Figure 1
<p>Overview of eye-tracking techniques and the eye-movement outcomes they detect.</p>
Full article ">
22 pages, 2399 KiB  
Review
The Role of Macronutrients and Gut Microbiota in Neuroinflammation Post-Traumatic Brain Injury: A Narrative Review
by Antonella Cotoia, Ioannis Alexandros Charitos, Alberto Corriero, Stefania Tamburrano and Gilda Cinnella
Nutrients 2024, 16(24), 4359; https://doi.org/10.3390/nu16244359 - 18 Dec 2024
Viewed by 285
Abstract
Traumatic brain injury (TBI) represents a multifaceted pathological condition resulting from external forces that disrupt neuronal integrity and function. This narrative review explores the intricate relationship between dietary macronutrients, gut microbiota (GM), and neuroinflammation in the TBI. We delineate the dual aspects of [...] Read more.
Traumatic brain injury (TBI) represents a multifaceted pathological condition resulting from external forces that disrupt neuronal integrity and function. This narrative review explores the intricate relationship between dietary macronutrients, gut microbiota (GM), and neuroinflammation in the TBI. We delineate the dual aspects of TBI: the immediate mechanical damage (primary injury) and the subsequent biological processes (secondary injury) that exacerbate neuronal damage. Dysregulation of the gut–brain axis emerges as a critical factor in the neuroinflammatory response, emphasizing the role of the GM in mediating immune responses. Recent evidence indicates that specific macronutrients, including lipids, proteins, and probiotics, can influence microbiota composition and in turn modulate neuroinflammation. Moreover, specialized dietary interventions may promote resilience against secondary insults and support neurological recovery post-TBI. This review aims to synthesize the current preclinical and clinical evidence on the potential of dietary strategies in mitigating neuroinflammatory pathways, suggesting that targeted nutrition and gut health optimization could serve as promising therapeutic modalities in TBI management. Full article
(This article belongs to the Special Issue Implications of Diet and the Gut Microbiome in Neuroinflammation)
Show Figures

Figure 1

Figure 1
<p>The gut microbiota undergoes significant changes following traumatic brain injury (TBI), characterized by the depletion of beneficial species such as <span class="html-italic">Lactobacillus gasseri</span> and <span class="html-italic">Eubacterium ventriosum</span> and an increase in potentially harmful species like <span class="html-italic">Marvinbryantia formatexigens</span> and <span class="html-italic">Eubacterium sulci</span>. This dysbiosis may exacerbate systemic inflammation and negatively impact neurological recovery through the gut–brain axis.</p>
Full article ">Figure 2
<p>The main biochemical actions by the GM-friendly bacteria on the CNS.</p>
Full article ">Figure 3
<p>The figure demonstrates the influence of the CNS on the gut microbiota and vice versa. It also illustrates the hypothesis of the interconnection between the gut–brain axis and other axes of the microbiota and their influence on homeostasis for the health of the host.</p>
Full article ">Figure 4
<p>Some probiotic bacteria that influence the function and structure of neurons.</p>
Full article ">
16 pages, 655 KiB  
Article
Factors Affecting Sport-Related Concussion Non-Disclosure in Women’s Rugby—A Multi-Country Qualitative Analysis
by Lisa Ryan, Ed Daly and Katherine Hunzinger
J. Funct. Morphol. Kinesiol. 2024, 9(4), 277; https://doi.org/10.3390/jfmk9040277 - 18 Dec 2024
Viewed by 310
Abstract
Background and Objectives: Collision-sport athletes, such as rugby players, are at risk of sport-related concussion (SRC). Women are known to be at higher risk of SRC and may experience more severe and chronic symptomology than men. Knowledge of the factors that affect a [...] Read more.
Background and Objectives: Collision-sport athletes, such as rugby players, are at risk of sport-related concussion (SRC). Women are known to be at higher risk of SRC and may experience more severe and chronic symptomology than men. Knowledge of the factors that affect a player’s disclosure of their concussive symptoms could help to inform strategies to improve compliance with reporting and management of head injuries. The aim of this study was to investigate the factors that may impact women rugby players’ disclosure of a concussion. Methods: Twenty-eight adult (≥18 years of age) elite and semi-elite women rugby players from the UK and Ireland (n = 17) and the United States (n = 11) were interviewed on their playing background and SRC experience in women’s rugby via one-on-one interviews (UK and Ireland) or an online questionnaire (US). Results: SRC data were analysed inductively using a thematic analysis approach to determine the potential reasons for SRC non-disclosure in women’s rugby. Four main themes were identified which may influence a player’s SRC non-disclosure: 1. women rugby players are self-managing SRC; 2. work-related concerns impact on SRC disclosure; 3. players and support staff lack knowledge on SRC management; and 4. poor internal and external communication affect the support players receive when injured. Conclusions: The findings were consistent across players from different countries. This research highlighted several factors that may impact on women rugby players’ disclosure of SRC regardless of country of origin (UK, Ireland, or US) and access to concussion care. Coaches and management teams should be aware of these reasons, which may enhance how they discuss and manage concussion. There is a clear need for further education on concussion for players and support staff and for strategies to create environments where women can openly discuss their concussion concerns. Full article
(This article belongs to the Special Issue Understanding Sports-Related Health Issues, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Proposed flow of communication for injury management. Communication needs to flow horizontally (between medical staff and coaching staff) and vertically between players’ clubs and their international camps.</p>
Full article ">
23 pages, 842 KiB  
Systematic Review
Neuromechanical Models of Mild Traumatic Brain Injury Conditioned on Reaction Time: A Systematic Review and Meta-Analysis
by Avinash Baskaran, Ross D. Hoehn and Chad G. Rose
J. Clin. Med. 2024, 13(24), 7648; https://doi.org/10.3390/jcm13247648 - 16 Dec 2024
Viewed by 323
Abstract
The accurate, repeatable, and cost-effective quantitative characterization of mild traumatic brain injuries (mTBIs) is crucial for safeguarding the long-term health and performance of high-risk groups, including athletes, emergency responders, and military personnel. However, gaps remain in optimizing mTBI assessment methods, especially regarding the [...] Read more.
The accurate, repeatable, and cost-effective quantitative characterization of mild traumatic brain injuries (mTBIs) is crucial for safeguarding the long-term health and performance of high-risk groups, including athletes, emergency responders, and military personnel. However, gaps remain in optimizing mTBI assessment methods, especially regarding the integration of neuromechanical metrics such as reaction time (RT) in predictive models. Background/Objectives: This review synthesizes existing research on the use of neuromechanical probabilistic models as tools for assessing mTBI, with an emphasis on RT’s role in predictive diagnostics. Methods: We examined 57 published studies on recent sensing technologies such as advanced electromyographic (EMG) systems that contribute data for probabilistic neural imaging, and we also consider measurement models for real-time RT tracking as a diagnostic measure. Results: The analysis identifies three primary contributions: (1) a comprehensive survey of probabilistic approaches for mTBI characterization based on RT, (2) a technical examination of these probabilistic algorithms in terms of reliability and clinical utility, and (3) a detailed outline of experimental requirements for using RT-based metrics in psychomotor tasks to advance mTBI diagnostics. Conclusions: This review provides insights into implementing RT-based neuromechanical metrics within experimental frameworks for mTBI diagnosis, suggesting that such metrics may enhance the sensitivity and utility of assessment and rehabilitation protocols. Further validation studies are recommended to refine RT-based probabilistic models for mTBI applications. Full article
Show Figures

Figure 1

Figure 1
<p>Existing mTBI assessment tools quantify patients’ reaction dynamics through physical observations by clinicians and are often overly coarse, generalizing, and challenging to perform accurately at the point of injury. Novel methods, including myography and portable neuro-imaging, have enabled robust, fine, and accurate measurement of reaction dynamics associated with mTBI at the point of injury, but the scientific literature reports a wide variety of disparate modeling approaches that frustrate methods to integrate RT into conventional mTBI assessment. This results in a broken chain between fast, reliable RT measurement and mTBI assessment. This work addresses this challenge by presenting and comparing models in the literature for mTBI characterization based on RT, examining the reliability and clinical utility of these models and detailing experimental requirements for using these models in mTBI diagnostics. This provides engineers, clinicians, and researchers with a guide to selecting and implementing mTBI models.</p>
Full article ">Figure 2
<p>Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart illustrating the data retrieval protocol used in this work.</p>
Full article ">Figure 3
<p>We extracted features pertaining to seven data categories (listed above) from each of the 57 studies selected for review. Quantitative items, including sample size, and statistical significance are used later on to characterize the neuromechanical models used in the studies.</p>
Full article ">Figure 4
<p>Above, a histogram of model types used in the selected studies (<b>top</b>) and a map linking inputs to outputs through models used in the selected studies (<b>bottom</b>) are shown. The lines shown in the map represent hypotheses. The thicker dark lines represent the most common hypotheses evaluated, the thinner dark lines represent the lesS common, and the dotted lines represent the least common hypotheses evaluated. The most commonly evaluated hypotheses were that experimental conditions including cognitive constraints (GCC, e.g., distraction tasks) and reaction time constraints (RTC, e.g., timed tasks) can be linked to neural activity (NAM) and cognitive performance (CPM) through time–frequency analysis and stochastic modeling.</p>
Full article ">Figure 5
<p>Visual representations of the log sum of Stouffer Z-scores and BMA weights across the various models tested are shown. The study indicates high utility and reliability of analytical time–frequency models and less reliability of machine learning models.</p>
Full article ">
17 pages, 5155 KiB  
Article
Neuroprotective Effects of Functionalized Hydrophilic Carbon Clusters: Targeted Therapy of Traumatic Brain Injury in an Open Blast Rat Model
by Parasuraman Padmanabhan, Jia Lu, Kian Chye Ng, Dinesh Kumar Srinivasan, Kumar Sundramurthy, Lizanne Greer Nilewski, William K. A. Sikkema, James M. Tour, Thomas A. Kent, Balázs Gulyás and Jan Carlstedt-Duke
Biomedicines 2024, 12(12), 2832; https://doi.org/10.3390/biomedicines12122832 - 13 Dec 2024
Viewed by 329
Abstract
Traumatic brain injury (TBI) causes multiple cerebrovascular disruptions and oxidative stress. These pathological mechanisms are often accompanied by serious impairment of cerebral blood flow autoregulation and neuronal and glial degeneration. Background/Objectives: Multiple biochemical cascades are triggered by brain damage, resulting in reactive oxygen [...] Read more.
Traumatic brain injury (TBI) causes multiple cerebrovascular disruptions and oxidative stress. These pathological mechanisms are often accompanied by serious impairment of cerebral blood flow autoregulation and neuronal and glial degeneration. Background/Objectives: Multiple biochemical cascades are triggered by brain damage, resulting in reactive oxygen species production alongside blood loss and hypoxia. However, most currently available early antioxidant therapies lack capacity and hence sufficient efficacy against TBI. The aim of this study was to test a novel catalytic antioxidant nanoparticle to alleviate the damage occurring in blast TBI. Methods: TBI was elicited in an open blast rat model, in which the rats were exposed to the effects of an explosive blast. Key events of the post-traumatic chain in the brain parenchyma were studied using immunohistochemistry. The application of a newly developed biologically compatible catalytic superoxide dismutase mimetic carbon-based nanocluster, a poly-ethylene-glycol-functionalized hydrophilic carbon cluster (PEG-HCC), was tested post-blast to modulate the components of the TBI process. Results: The PEG-HCC was shown to significantly ameliorate neuronal loss in the brain cortex, the dentate gyrus, and hippocampus when administered shortly after the blast. There was also a significant increase in endothelial activity to repair blood–brain barrier damage as well as the modulation of microglial and astrocyte activity and an increase in inducible NO synthase in the cortex. Conclusions: We have demonstrated qualitatively and quantitatively that the previously demonstrated antioxidant properties of PEG-HCCs have a neuroprotective effect after traumatic brain injury following an explosive blast, acting at multiple levels of the pathological chain of events elicited by TBI. Full article
(This article belongs to the Special Issue Emerging Trends in Traumatic Brain Injury)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The timeline of the acute experiment from 3 h pre−blast to 3 h post−blast, showing transportation, blast exposure, and injection of the animals.</p>
Full article ">Figure 2
<p>The post-traumatic events in brain parenchyma, their interrelationships, and the neuronal markers used for their visualization and quantification in the present study. BBB—blood–brain barrier; CNPase—2′,3′-cyclic-nucleotide 3′-phosphodiesterase; GFAP—glial fibrillary acidic protein; Iba1—ionized calcium-binding adaptor molecule 1; iNOS—inducible nitric oxide synthase; NeuN—neuronal nuclei; RECA-1—rat endothelial cell antigen 1.</p>
Full article ">Figure 3
<p>(<b>A</b>) Cortex nuclei immunofluorescence analysis of neurons stained with antibodies to neuronal nuclei (NeuN) (green) and counterstained with 4′,6-diamidino-2-phenylindole (DAPI) for nuclei (blue): examples from the CONTROL (C), PEG (P), and SALINE (S) groups analyzed 3 (P3, S3) and 14 (P14, S14) days post-blast. (<b>B</b>) Average levels of NeuN (normalized to the control) in the PEG and SALINE groups. Coloured bar = mean; open bar = 1 S.D. (<b>C</b>) Statistically significant differences (+ refers to <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>(<b>A</b>) Dentate gyrus nuclear immunofluorescence analysis, labelling neurons with antibodies to neuronal nuclei (NeuN) (green) and counterstained with 4′,6-diamidino-2-phenylindole (DAPI) for nuclei (blue): examples from the CONTROL (C), PEG (P), and SALINE (S) groups analyzed 3 (P3, S3) and 14 (P14, S14) days post-blast. (<b>B</b>) Average levels of NeuN (normalized to the control) in the PEG and SALINE groups. Coloured bar = mean; open bar = 1 S.D. (<b>C</b>) Statistically significant differences (+ refers to <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>(<b>A</b>) Hippocampus nuclear immunofluorescence analysis labelling neurons with antibodies to neuronal nuclei (NeuN) (green) antibodies and counterstained with 4′,6-diamidino-2-phenylindole (DAPI) for nuclei (blue): examples from the CONTROL (C), PEG (P), and SALINE (S) groups analyzed 3 (P3, S3) and 14 (P14, S14) days post-blast. (<b>B</b>) Average levels of NeuN (normalized to the control) in the PEG and SALINE groups. Coloured bar = mean; open bar = 1 S.D. (<b>C</b>) Statistically significant differences (+ refers to <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 6
<p>(<b>A</b>) Rat endothelial cell antigen (RECA-1) (red) immunofluorescence labelling of cortical neurons that are counterstained with 4′,6-diamidino-2-phenylindole (DAPI) for nuclei (blue): examples from the CONTROL (C), PEG (P), and SALINE (S) groups analyzed 3 (P3, S3) and 14 (P14, S14) days post-blast. (<b>B</b>) Average levels of RECA-1 (normalized to the control) in the PEG and SALINE groups. Coloured bar = mean; open bar = 1 S.D. (<b>C</b>) Statistically significant differences (+ refers to <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 7
<p>(<b>A</b>) Immunofluorescence labelling of neurons that are stained with antibodies to ionized calcium-binding adaptor molecule 1 (Iba1) (green) and counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (blue) for nuclei in the cortex: examples from the PEG (P) and SALINE (S) groups analyzed 3 (P3, S3) and 14 (P14, S14) days post-blast. The smaller frames are higher-magnification views showing representative microglia cells. (<b>B</b>) The average number of labelled cells/field of view in the PEG and SALINE groups. Coloured bar = mean; open bar = 1 S.D. (<b>C</b>) Statistically significant differences (+ refers to <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 8
<p>(<b>A</b>) Immunofluorescence labelling of neurons that are stained with antibodies to glial fibrillary acidic protein (GFAP) (green) and counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (blue) for nuclei in the cortex: examples from the CONTROL (C), PEG (P), and SALINE (S) groups analyzed 3 (P3, S3) and 14 (P14, S14) days post-blast. (<b>B</b>) The average levels of GFAP (normalized to the control) in the PEG and SALINE groups. Coloured bar = mean; open bar = 1 S.D. (<b>C</b>) Statistically significant differences (+ refers to <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 9
<p>(<b>A</b>) Immunofluorescence labelling of neurons that are stained with antibodies to inducible nitic oxide synthase (iNOS) (green) and counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (blue) for nuclei in the cortex: examples from the CONTROL (C), PEG (P), and SALINE (S) groups analyzed 3 (P3, S3) and 14 (P14, S14) days post-blast. (<b>B</b>) The average levels of iNOS (normalized to the control) in the PEG and SALINE groups. Coloured bar = mean; open bar = 1 S.D. (<b>C</b>) Statistically significant differences (+ refers to <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 10
<p>(<b>A</b>) Immunofluorescence labelling of neurons that are stained with antibodies to 2′,3′-cyclic-nucleotide 3′-phosphodiesterase (CNPase) (red) and counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (blue) for nuclei in the cortex: examples from the CONTROL (C), PEG (P), and SALINE (S) groups analyzed 3 (P3, S3) and 14 (P14, S14) days post-blast. (<b>B</b>) Average levels of CNPase (normalized to the control) in the PEG and SALINE groups. Coloured bar = mean; open bar = 1 S.D. (<b>C</b>) Statistically significant differences (+ refers to <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
14 pages, 613 KiB  
Article
Patterns of Brain Injury and Clinical Outcomes Related to Trauma from Collisions Involving Motor Vehicles
by Bharti Sharma, Aubrey May B. Agcon, George Agriantonis, Samantha R. Kiernan, Navin D. Bhatia, Kate Twelker, Zahra Shafaee and Jennifer Whittington
J. Clin. Med. 2024, 13(24), 7500; https://doi.org/10.3390/jcm13247500 - 10 Dec 2024
Viewed by 327
Abstract
Background: Despite improvements in technology and safety measures, injuries from collisions involving motor vehicles (CIMVs) continue to be prevalent. Therefore, our goal is to investigate the different patterns of head injuries associated with CIMVs. Method: This is a single-center, retrospective study [...] Read more.
Background: Despite improvements in technology and safety measures, injuries from collisions involving motor vehicles (CIMVs) continue to be prevalent. Therefore, our goal is to investigate the different patterns of head injuries associated with CIMVs. Method: This is a single-center, retrospective study of patients with motor vehicle-related trauma between 1 January 2016–31 December 2023. Patients were identified based on the International Classification of Diseases (ICD) injury codes and the Abbreviated Injury Severity (AIS) for body region involvement. Result: 536 patients met the inclusion criteria. The majority of the injured population includes pedestrians (46.8%), followed by motorcycle drivers (25.2%), bicyclists (18.7%), and motor vehicle drivers (9.3%). The male-to-female ratios for bicyclists and motorcyclists were 13.7:1 and 11.9:1, respectively, which is higher compared with motor vehicle occupants and pedestrians, with ratios of 2.3:1 and 1.5:1. Patients with blunt trauma (99.63%) were higher than penetrating trauma (0.37%). In most cases, the head had the highest AIS score, with a mean of 3.7. Additionally, the median Injury Severity Score (ISS) was 20. Skull fractures were the most prevalent, followed by hemorrhages, lacerations, contusions, and abrasions. Conclusions: The most prevalent injuries were head injuries and fractures. Fractures were the most common, followed by hemorrhage, laceration, contusion, and abrasion. These findings underscore the high incidence of TBI and fractures in such CIMVs, highlighting the need for targeted trauma interventions and the need for injury prevention strategies to mitigate these severe outcomes. Full article
(This article belongs to the Special Issue Clinical Advances in Traumatic Brain Injury)
Show Figures

Figure 1

Figure 1
<p>Receiver Operating Characteristic (ROC) curve comparison for four predictive models evaluating discharge outcomes.</p>
Full article ">
23 pages, 4842 KiB  
Article
Evaluation of Snowboarding Helmets in Mitigation of the Biomechanical Responses of Head Surrogate
by Atul Harmukh and Shailesh G. Ganpule
Appl. Sci. 2024, 14(23), 11460; https://doi.org/10.3390/app142311460 - 9 Dec 2024
Viewed by 601
Abstract
Traumatic brain injury (TBI) during snowboarding sports is a major concern. A robust evaluation of existing snowboarding helmets is desired. Head kinematics (i.e., linear acceleration, angular velocity, angular acceleration) and associated brain responses (brain pressure, equivalent (von Mises) stress, and maximum principal strain) [...] Read more.
Traumatic brain injury (TBI) during snowboarding sports is a major concern. A robust evaluation of existing snowboarding helmets is desired. Head kinematics (i.e., linear acceleration, angular velocity, angular acceleration) and associated brain responses (brain pressure, equivalent (von Mises) stress, and maximum principal strain) of the head are a predominant cause of TBI or concussion. The conventional snowboarding helmet, which mitigates linear acceleration, is typically used in snow sports. However, the role of conventional snowboarding helmets in mitigating angular head kinematics is marginal or insignificant. In recent years, new anti-rotational technologies (e.g., MIPS, WaveCel) have been developed that seek to reduce angular kinematics (i.e., angular velocity, angular acceleration). However, investigations regarding the performance of snowboarding helmets in terms of the mitigation of head kinematics and brain responses are either extremely limited or not available. Toward this end, we have evaluated the performance of snowboarding helmets (conventional and anti-rotational technologies) against blunt impact. We also evaluated the performance of newly developed low-cost, silica-based anti-rotational pads by integrating them with conventional helmets. Helmets were mounted on a head surrogate–Hybrid III neck assembly. The head surrogate consisted of skin, skull, dura mater, and brain. The geometry of the head surrogate was based on the GHBMC head model. Substructures of the head surrogate was manufactured using additive manufacturing and/or molding. A linear impactor system was used to simulate/recreate snowfield hazards (e.g., tree stump, rock, pole) loading. Following the ASTM F2040 standard, an impact velocity of 4.6 ± 0.2 m/s was used. The head kinematics (i.e., linear acceleration, angular velocity, angular acceleration) and brain simulant pressures were measured in the head surrogate. Further, using the concurrent simulation, the brain simulant responses (i.e., pressure, von Mises stress, and maximum principal strain) were computed. The front and side orientations were considered. Our results showed that the helmets with anti-rotation technologies (i.e., MIPS, WaveCel) significantly reduced the angular kinematics and brain responses compared to the conventional helmet. Further, the performance of the silica pad-based anti-rotational helmet was comparable to the existing anti-rotational helmets. Lastly, the effect of a comfort liner on head kinematics was also investigated. The comfort liner further improved the performance of anti-rotational helmets. Overall, these results provide important data and novel insights regarding the performance of various snowboarding helmets. These data have utility in the design and development of futuristic snowboarding helmets and safety protocols. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Photographs of the 3D-printed head surrogate integrated with Hybrid III neck (the skin is not shown for the clarity of the photographs), (<b>b</b>) a midsagittal view of the head surrogate for the visualization of the skin, skull, dura mater, and brain simulant.</p>
Full article ">Figure 2
<p>Photographs of helmets used in this study (<b>a</b>) conventional helmet, (<b>b</b>) MIPS helmet, (<b>c</b>) WaveCel helmet, (<b>d</b>) silica pad helmet (for the clarity of the photograph of the helmet, only 2 silicas are shown; however, 10 silica pads are present in between the comfort liner and impact mitigation liner).</p>
Full article ">Figure 3
<p>(<b>a</b>) A schematic of the linear impactor setup, (<b>b</b>) a photograph depicting the instrumentation in the head surrogate used for front orientation (skin is not shown for the clarity of the photograph), (<b>c</b>) a photograph depicting the instrumentation in the head surrogate used for the side orientation (skin is not shown for the clarity of the photograph), (<b>d</b>) a schematic depicting the pressure sensor locations within the brain simulant for front orientation impact, (<b>e</b>) a schematic depicting the pressure sensor locations within the brain simulant for side orientation impact (the pressure sensor is shown in the top corner).</p>
Full article ">Figure 4
<p>Kinematic response (peak angular velocity, peak angular acceleration, peak linear acceleration) of the head surrogate, (<b>a</b>–<b>c</b>) and (<b>d</b>–<b>f</b>) depict the kinematic response for front and side orientations, respectively. * Indicates statistically significant changes (<span class="html-italic">p</span> &lt; 0.05) compared to no helmet. ** indicates statistically significant changes (<span class="html-italic">p</span> &lt; 0.05) compared to the conventional helmet.</p>
Full article ">Figure 5
<p>Kinetic response (brain simulant pressures) of the head surrogate: positive and negative values represent the coup and contrecoup pressures, respectively, in the brain simulant. (<b>a</b>,<b>b</b>) depicts the brain simulant pressures for the front and side orientations, respectively. * Indicates statistically significant changes (<span class="html-italic">p</span> &lt; 0.05) compared to no helmet. ** Indicates statistically significant changes (<span class="html-italic">p</span> &lt; 0.05) compared to the conventional helmet.</p>
Full article ">Figure 6
<p>Kinematic response of head surrogate with conventional and anti-rotational helmets (‘with comfort liner’ and ‘without comfort liner’). (<b>a</b>–<b>c</b>) and (<b>d</b>–<b>f</b>) depict the kinematic response for front and side orientations, respectively. * Shows the significant changes (<span class="html-italic">p</span> &lt; 0.05) in the ‘without comfort liner’ helmet configurations compared to the ‘with comfort liner’ helmet configurations.</p>
Full article ">Figure 7
<p>Spatiotemporal evolution of brain simulant pressure in the front (<b>a</b>) and side (<b>b</b>) orientations. Here, rows A, B, C, D, and E represent the no-helmet, conventional helmet, MIPS helmet, WaveCel helmet, and silica pad helmet configurations, respectively.</p>
Full article ">Figure 8
<p>Spatiotemporal evolution of equivalent (von Mises) stress (<b>a</b>,<b>b</b>), and MPS (<b>c</b>,<b>d</b>) in the brain simulant for front and side orientations. Here, rows A, B, C, D, and E represent the no-helmet, conventional helmet, MIPS helmet, WaveCel helmet, and silica pad helmet configurations, respectively.</p>
Full article ">
15 pages, 1335 KiB  
Article
Lactate Is a Strong Predictor of Poor Outcomes in Patients with Severe Traumatic Brain Injury
by Bharti Sharma, Winston Jiang, Yashoda Dhole, George Agriantonis, Navin D. Bhatia, Zahra Shafaee, Kate Twelker and Jennifer Whittington
Biomedicines 2024, 12(12), 2778; https://doi.org/10.3390/biomedicines12122778 - 6 Dec 2024
Viewed by 500
Abstract
Background: Lactate is a byproduct of glycolysis, often linked to oxygen deprivation. This study aimed to examine how lactate levels (LLs) affect clinical outcomes in patients with severe TBI, hypothesizing that higher LLs would correlate with worse outcomes. Methods: This is a [...] Read more.
Background: Lactate is a byproduct of glycolysis, often linked to oxygen deprivation. This study aimed to examine how lactate levels (LLs) affect clinical outcomes in patients with severe TBI, hypothesizing that higher LLs would correlate with worse outcomes. Methods: This is a level 1 single-center, retrospective study of patients with severe TBI between 1 January 2020 and 31 December 2023, inclusive. Results: Single-factor ANOVA indicated a significant decrease in LLs with increasing age. Linear regression models showed the same for hospital admission, Intensive Care Unit (ICU) admission LLs, and death LLs. Prognostic scores such as Injury Severity Scores (ISS) and Glasgow Coma Score (GCS) showed a strong correlation with both Hospital admission and ICU admission LLs. ANOVA indicated higher LLs with increasing ISS and increasing LLs with decreasing GCS. Linear regressions revealed a strong positive correlation between ISS and LLs. On linear regression, the LL measured at hospital admission and ICU admission was positively associated with the length of stay (LOS) in the hospital, LOS in the ICU, ventilator days, and mortality. Linear regression models showed that a decreased delta LL during ICU admission led to an increased LOS at the hospital and the ICU, as well as a higher number of days on a ventilator. Discussion: We discovered that high LLs were linked to higher AIS and GCS scores, longer stays in the hospital and ICU, more days requiring a ventilator, and higher mortality rates in patients with severe TBI. Conclusions: LLs can be considered a strong predictor of poor clinical outcomes in patients with severe TBI. Full article
(This article belongs to the Section Neurobiology and Clinical Neuroscience)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>This figure outlines the distributions of injury mechanisms for each of the six traumatic brain injury (TBI) diagnoses. Each diagnosis displays the number of patients within each of the seven mechanisms of injury categories. It shows the different classifications of intracranial injuries with stratification by the mechanism of injury and the number of incidences of each that was seen in our study sample, with falls being by far the most common mechanism of injury, particularly in subdural and subarachnoid hemorrhage.</p>
Full article ">Figure 2
<p>Linear regression analysis demonstrates a statistically significant correlation between admission LLs and hospital length of stay (LOS), measured in days. The line of best fit with confidence intervals shows a gradual upward trend and a positive correlation between the lactate level at admission and the hospital LOS. The correlation coefficient between lactate level at admission and hospital LOS was 0.7903.</p>
Full article ">Figure 3
<p>This illustrates a box plot indicating average LLs among patients who survived their injury and those who experienced death during hospitalization. Average admission LL was significantly higher for cases with mortality. Average LLs upon admission to the trauma bay among patients who survived their injury were lower than those who died during the hospitalization, with 0 indicating patients who survived and 1 indicating patients who did not.</p>
Full article ">
10 pages, 6297 KiB  
Case Report
Spontaneous Resolution of an Aggressive Direct Carotid Cavernous Fistula Following Partial Transvenous Embolization Treatment: A Case Report and Review of Literatures
by Wen-Jui Liao, Chun-Yuan Hsiao, Chin-Hsiu Chen, Yuan-Yun Tseng and Tao-Chieh Yang
Medicina 2024, 60(12), 2011; https://doi.org/10.3390/medicina60122011 - 5 Dec 2024
Viewed by 424
Abstract
Traumatic direct type carotid cavernous fistula (CCF) is an acquired arteriovenous shunt between the carotid artery and the cavernous sinus post severe craniofacial trauma or iatrogenic injury. We reported a 46-year-old woman who had developed a traumatic direct type CCF after severe head [...] Read more.
Traumatic direct type carotid cavernous fistula (CCF) is an acquired arteriovenous shunt between the carotid artery and the cavernous sinus post severe craniofacial trauma or iatrogenic injury. We reported a 46-year-old woman who had developed a traumatic direct type CCF after severe head trauma with a skull base fracture and brain contusion hemorrhage. The clinical manifestations of the patient included pulsatile exophthalmos, proptosis, bruits, chemosis, and a decline in consciousness. Magnetic resonance imaging (MRI) revealed engorgement of the right superior ophthalmic vein (SOV), perifocal cerebral edema in the right frontal–temporal cortex, right basal ganglia, and brain stem. Digital subtraction angiography (DSA) disclosed a direct type high-flow CCF with an aggressive cortical venous reflux drainage pattern, which was attributed to Barrow type A and Thomas classification type 5. After partial treatment by transvenous coil embolization for the CCF, the residual high-flow fistula with aggressive venous drainage had an unusual rapid spontaneous resolution in a brief period. Therefore, it is strongly recommended to meticulously monitor the clinical conditions of patients and perform brain MRI and DSA at short intervals to determine the treatment strategy for residual CCF after partial endovascular treatment. Full article
(This article belongs to the Section Neurology)
Show Figures

Figure 1

Figure 1
<p>The figure reveals a small subdural hematoma over the right temporal lobe (arrow), sylvian subarachnoid hemorrhage, and right sellar floor fracture with sphenoid sinus hematoma.</p>
Full article ">Figure 2
<p>(<b>a</b>) Right eye proptosis and conjunctiva vessel engorgement, without chemosis. (<b>b</b>) Rapidly progressive severe right eye exophthalmos and chemosis developed in several days. (<b>c</b>) After 1 month of treatment, the right eye had a full recovery without strabismus.</p>
Full article ">Figure 3
<p>(<b>a</b>) Brain magnetic resonance imaging (MRI) axial view, T1-weighted imaging with contrast disclosed engorgement of right superior ophthalmic vein (arrow head), and swelling of right orbital cavity (star); (<b>b</b>) brain MRI axial view, T2-weighted imaging show high T2 signal change in right corpus striatum; and (<b>c</b>) axial view of brain MRI T2-weighted imaging show enhancement at right insular lobe, right frontal inferior lobe, right medial temporal lobe, midbrain, and pons, which indicate perifocal cerebral edema.</p>
Full article ">Figure 4
<p>(<b>a</b>,<b>b</b>) Digital subtraction angiography (DSA) anterior–posterior view (AP) and lateral (Lat) view show a direct type high-flow CCF on the right-side ICA with reflux flow into the right superior/inferior ophthalmic vein (arrow head), the right superficial middle cerebral vein (star), the right superior petrosal sinus (arrow), and the right inferior petrosal sinus (triangular). Right facial vein engorgement due to right superior/inferior ophthalmic vein drainage was also noticed in the DSA (circle); (<b>c</b>,<b>d</b>) The Guglielmi Detachable Coils (GDCs) were deployed into the CCF, resulting in occlusion of the anterior drainage part of CCF (arrow head). There were still two fistulous points in the back part of the CCF that showed severe arteriovenous shunts: one at the right sphenoparietal sinus drainage into the right superficial middle cerebral vein (star), and another at the right superior petrosal sinus (arrow). This caused severe cortical vein reflux.</p>
Full article ">Figure 4 Cont.
<p>(<b>a</b>,<b>b</b>) Digital subtraction angiography (DSA) anterior–posterior view (AP) and lateral (Lat) view show a direct type high-flow CCF on the right-side ICA with reflux flow into the right superior/inferior ophthalmic vein (arrow head), the right superficial middle cerebral vein (star), the right superior petrosal sinus (arrow), and the right inferior petrosal sinus (triangular). Right facial vein engorgement due to right superior/inferior ophthalmic vein drainage was also noticed in the DSA (circle); (<b>c</b>,<b>d</b>) The Guglielmi Detachable Coils (GDCs) were deployed into the CCF, resulting in occlusion of the anterior drainage part of CCF (arrow head). There were still two fistulous points in the back part of the CCF that showed severe arteriovenous shunts: one at the right sphenoparietal sinus drainage into the right superficial middle cerebral vein (star), and another at the right superior petrosal sinus (arrow). This caused severe cortical vein reflux.</p>
Full article ">Figure 5
<p>(<b>a</b>) Brain MRI was followed up 3 days after endovascular treatment: axial view of brain MRI T1-weighted imaging with contrast disclosed significantly decreased engorgement of the right superior ophthalmic vein (arrow head); (<b>b</b>,<b>c</b>) brain MRI axial view, T2-weighted imaging showed less perifocal edema in the right corpus striatum, midbrain, and pons comparing to the condition before endovascular treatment.</p>
Full article ">Figure 6
<p>(<b>a</b>,<b>b</b>) The AP and Lat DSA views revealed the residual CCF had spontaneously resolved without additional cortical reflux.</p>
Full article ">
9 pages, 210 KiB  
Case Report
Impact of COVID-19 Pandemic-Related Restrictions for Inpatients with Aphasia and Associated Cognitive Dysfunction: Lessons Learned from Patient Detention
by Edwin Eshun, Killian Welch, Hannah Britton, Victoria Mayer, Fay Morrice, Charlotte Ogilvie, Helen Page, Jessie Pridmore and Alasdair FitzGerald
COVID 2024, 4(12), 1951-1959; https://doi.org/10.3390/covid4120137 - 4 Dec 2024
Viewed by 540
Abstract
We describe two patients with a recent stroke or traumatic brain injury associated with aphasia and cognitive impairment who required detention (under the Mental Health Act) as well as some form of restraint during their inpatient rehabilitation. Each of these episodes of care [...] Read more.
We describe two patients with a recent stroke or traumatic brain injury associated with aphasia and cognitive impairment who required detention (under the Mental Health Act) as well as some form of restraint during their inpatient rehabilitation. Each of these episodes of care occurred early into the COVID-19 pandemic and we speculate that the detention (and restraint) was attributable, at least in part, to the difficulty in comprehending COVID-19-related changes in patterns of staff interaction and the mandated social and visiting restrictions. We reflect on the impact of these restrictions on the need for detention and how these factors could have been mitigated through speech and language therapist (SLT) and broader multidisciplinary team (MDT) intervention. Full article
16 pages, 1286 KiB  
Review
Resuscitation and Initial Management After Moderate-to-Severe Traumatic Brain Injury: Questions for the On-Call Shift
by Jesús Abelardo Barea-Mendoza, Mario Chico-Fernández, Maria Angeles Ballesteros, Alejandro Caballo Manuel, Ana M. Castaño-Leon, J. J. Egea-Guerrero, Alfonso Lagares, Guillermo Morales-Varas, Jon Pérez-Bárcena, Luis Serviá Goixart and Juan Antonio Llompart-Pou
J. Clin. Med. 2024, 13(23), 7325; https://doi.org/10.3390/jcm13237325 - 2 Dec 2024
Viewed by 714
Abstract
Traumatic brain injury (TBI) is a leading cause of disability and mortality globally, stemming from both primary mechanical injuries and subsequent secondary responses. Effective early management of moderate-to-severe TBI is essential to prevent secondary damage and improve patient outcomes. This review provides a [...] Read more.
Traumatic brain injury (TBI) is a leading cause of disability and mortality globally, stemming from both primary mechanical injuries and subsequent secondary responses. Effective early management of moderate-to-severe TBI is essential to prevent secondary damage and improve patient outcomes. This review provides a comprehensive guide for the resuscitation and stabilization of TBI patients, combining clinical experience with current evidence-based guidelines. Key areas addressed in this study include the identification and classification of severe TBI, intubation strategies, and optimized resuscitation targets to maintain cerebral perfusion. The management of coagulopathy and special considerations for patients with concomitant hemorrhagic shock are discussed in depth, along with recommendations for neurosurgical interventions. This article further explores the role of multimodal neuromonitoring and targeted temperature management to mitigate secondary brain injury. Finally, it discusses end-of-life care in cases of devastating brain injury (DBI). This practical review integrates foundational and recent advances in TBI management to aid in reducing secondary injuries and enhancing long-term recovery, presenting a multidisciplinary approach to support acute care decisions in TBI patients. Full article
(This article belongs to the Special Issue Neurocritical Care: New Insights and Challenges)
Show Figures

Figure 1

Figure 1
<p>The HEAD bundle for intubation.</p>
Full article ">Figure 2
<p>Approach to reversal of anticoagulation in traumatic brain hemorrhage. PCC: four-factor prothrombin complex concentrate; INR: international normalized ratio; CT: computed tomography; max: maximum; IU: international units; g: grams; mg: milligrams. * In patients with TBI and normal CT, it is advisable to discontinue anticoagulation, perform an observation period, and repeat CT before restarting anticoagulation. † Activated charcoal is used in spontaneous cerebral hemorrhage if the last intake is less than 8 h. In traumatic brain hemorrhage, it may interfere with the initial care of major trauma.</p>
Full article ">Figure 3
<p>Neuroimaging workflow in moderate-to-severe TBI. * If DAI is suspected (unexplained neurological findings), schedule an MRI. † In patients with early (&lt;2–3 h from injury) initial pathological CT scan, consider earlier follow-up.</p>
Full article ">
35 pages, 1863 KiB  
Review
Omega-3 Fatty Acids and Traumatic Injury in the Adult and Immature Brain
by Ester Valero-Hernandez, Jordi L. Tremoleda and Adina T. Michael-Titus
Nutrients 2024, 16(23), 4175; https://doi.org/10.3390/nu16234175 - 30 Nov 2024
Viewed by 841
Abstract
Background/Objectives: Traumatic brain injury (TBI) can lead to substantial disability and health loss. Despite its importance and impact worldwide, no treatment options are currently available to help protect or preserve brain structure and function following injury. In this review, we discuss the potential [...] Read more.
Background/Objectives: Traumatic brain injury (TBI) can lead to substantial disability and health loss. Despite its importance and impact worldwide, no treatment options are currently available to help protect or preserve brain structure and function following injury. In this review, we discuss the potential benefits of using omega-3 polyunsaturated fatty acids (O3 PUFAs) as therapeutic agents in the context of TBI in the paediatric and adult populations. Methods: Preclinical and clinical research reports investigating the effects of O3 PUFA-based interventions on the consequences of TBI were retrieved and reviewed, and the evidence presented and discussed. Results: A range of animal models of TBI, types of injury, and O3 PUFA dosing regimens and administration protocols have been used in different strategies to investigate the effects of O3 PUFAs in TBI. Most evidence comes from preclinical studies, with limited clinical data available thus far. Overall, research indicates that high O3 PUFA levels help lessen the harmful effects of TBI by reducing tissue damage and cell loss, decreasing associated neuroinflammation and the immune response, which in turn moderates the severity of the associated neurological dysfunction. Conclusions: Data from the studies reviewed here indicate that O3 PUFAs could substantially alleviate the impact of traumatic injuries in the central nervous system, protect structure and help restore function in both the immature and adult brains. Full article
Show Figures

Figure 1

Figure 1
<p>Neuropathological aspects of TBI are alleviated after omega-3 PUFA interventions. TBI leads to a number of changes in brain structure and function; some key changes are depicted in the figure (black). O3 PUFA compounds such as DHA or EPA modulate these injury-induced effects (blue), as indicated by preclinical studies in animal models of TBI, where a combination of histological markers, neuroimaging techniques, and behavioural analyses (brown) have been used to study each individual component (list of markers not exhaustive). APP: beta-amyloid precursor protein, AQP-4: aquaporin 4, Bax: Bcl-2-associated X protein, Bcl-2: B-cell lymphoma-2, CD68: cluster of differentiation 68, COX-2: cyclooxygenase-2, GFAP: glial fibrillary acidic protein, Iba1: ionized calcium-binding adapter molecule 1, IL-1β/6: interleukin 1 beta or 6, iNOS: inducible nitric oxide synthase, MBP: myelin binding protein, MMP: matrix metallopeptidase, MRI: magnetic resonance imaging, NF: neurofilament, NF-κB: nuclear factor kappa B, Nrf2: nuclear factor erythroid 2–related factor 2, TNF-α: tumour necrosis factor-alpha, 4-HHE: 4-hydroxy-2-hexenal, 4-HNE: 4-hydroxynonenal, 8-OHG: 8-hydroxyguanosine.</p>
Full article ">
15 pages, 12026 KiB  
Article
Neural Cell Interactions with a Surgical Grade Biomaterial Using a Simulated Injury in Brain Organotypic Slices
by Jessica Patricia Wiseman and Divya Maitreyi Chari
J. Funct. Biomater. 2024, 15(12), 362; https://doi.org/10.3390/jfb15120362 - 30 Nov 2024
Viewed by 607
Abstract
Tissue engineering research for neurological applications has demonstrated that biomaterial-based structural bridges present a promising approach for promoting regeneration. This is particularly relevant for penetrating traumatic brain injuries, where the clinical prognosis is typically poor, with no available regeneration-enhancing therapies. Specifically, repurposing clinically [...] Read more.
Tissue engineering research for neurological applications has demonstrated that biomaterial-based structural bridges present a promising approach for promoting regeneration. This is particularly relevant for penetrating traumatic brain injuries, where the clinical prognosis is typically poor, with no available regeneration-enhancing therapies. Specifically, repurposing clinically approved biomaterials offers many advantages (reduced approval time and achieving commercial scaleup for clinical applications), highlighting the need for detailed screening of potential neuromaterials. A major challenge in experimental testing is the limited availability of neuromimetic, technically accessible, cost-effective, and humane models of neurological injury for efficient biomaterial testing in injury-simulated environments. Three dimensional (3D) organotypic brain slices bridge the gap between live animal models and simplified co-cultures and are a versatile tool for studies on neural development, neurodegenerative disease and in drug testing. Despite this, their utility for investigation of neural cell responses to biomaterial implantation is poorly investigated. We demonstrate that murine brain organotypic slices can be used to develop a model of penetrating traumatic brain injury, wherein a surgical-grade biomaterial scaffold can be implanted into the lesion cavity. Critically, the model allowed for examination of key cellular responses involved in CNS injury pathology/biomaterial handling: astrogliosis, microglial activation and axonal sprouting. The approach offers a technically simple and versatile methodology to study biomaterial interventions as a regenerative therapy for neurological injuries. Full article
Show Figures

Figure 1

Figure 1
<p>Viability of control and injured bOSCs. Representative micrographs of control, uninjured bOSCs at 11 DIV (<b>A</b>) 4 DIV + 7 DPL (<b>B</b>), 18 DIV (<b>C</b>) or 4 DIV + 14 PDL (<b>D</b>). Merged images are shown are for calcein (live cells) and EthD-1 (dead cells), with the corresponding EthD-1 only stain below the corresponding merged image. White arrows highlight dead cells localised to the slice edge of the lesion margins; yellow arrows indicate cell death within the body of the slice at later timepoints.</p>
Full article ">Figure 2
<p>Astrocytes display enhanced GFAP reactivity at the injury site and biomaterial implantation at the lesion supports astrocytic ingrowth (14 DPL). (<b>A</b>) Representative micrograph of normal appearing morphologies in a dense syncytium of astrocytes distributed throughout the bOSCs at 18 DIV. (<b>B</b>) Representative micrograph of injury-induced astrogliosis at the lesion margin, including a band of intense GFAP expression and a glial-scar like interconnected network of astrocytes at 14 DPL (shown in higher magnification in (<b>B1</b>)). (<b>B2</b>) displays little or no astrogliosis in astrocytes distant from the lesion margins. White arrows indicate the band of increased GFAP staining. (<b>C</b>) Phase contrast images of the lesion area pre- and post-DG implantation (at 0 DPL) where the material can be observed filling the lesion cavity. Blue arrows identify the implanted biomaterial sheet. The purple arrow indicates the biomaterial-slice interface. (<b>D</b>) At 14 DPL, there was extensive astrocytic ingrowth into the DG implant, with an apparent disruption of the glial scar-like structure. Astrocytes in the material varied in levels of GFAP expression. The dashed line indicates the lesion margins. (<b>D1</b>) Magnified view of ((<b>D</b>), white box) displays that astrocytes at the biomaterial–slice interface show varying levels of GFAP expression and a range of cellular morphologies. (<b>E</b>) Bar graph presents the average glial scar width per biological repeat. There are no significant differences between data. Data are presented as mean ± SEM and analysed by a one-way ANOVA with Tukey’s multiple comparisons test, (<span class="html-italic">n</span> = 3). (<b>F</b>) Graph demonstrates a significant increase in GFAP expression (optical density measurements) at the lesion margins of injury-only slices compared to the baseline GFAP expression 400–500 µm from the lesion site. Injury + DG implantation showed no obvious enhancement or reduction in GFAP reactivity. Data are presented as mean ± SEM and analysed by a two-way ANOVA with Tukey’s multiple comparisons test, <span class="html-italic">n</span> = 4, asterisks indicate * <span class="html-italic">p</span> &lt; 0.1, ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 3
<p>Limited axonal outgrowth observed with or without biomaterial implantation (14 DPL). (<b>A</b>) Representative micrograph of the neuronal network within control, uninjured slices (18 DIV). (<b>B</b>) Restricted axonal outgrowth was observed from the lesion margins in injury-only slices (14 DPL). (<b>C</b>) Higher magnification of (<b>B</b>) at the lesion edge confirms lack of axonal outgrowth. (<b>D</b>) DG implantation shows limited effects on axonal outgrowth into the material (14 DPL). Orange arrow indicates a single neurite extension into DG. Red arrow indicates majority of neurite growth along the lesion edge within the slice. Dashed lines indicate lesion margins (<b>B</b>,<b>C</b>) or material boundary (<b>D</b>).</p>
Full article ">Figure 4
<p>Microglia are observed to robustly colonise the biomaterial. (<b>A</b>) Representative micrograph of the injury-only slice, showing a low level of microglial infiltration (14 DPL). Dashed line indicates lesion edge. (<b>B</b>) Representative micrograph of the slice injury site with implanted DG, showing extensive microglial infiltration (14 DPL) compared to the injury alone. Dashed line indicates material boundary. (<b>C</b>–<b>E</b>) show a range of microglial morphologies with amoeboid (rounded) or bushy activated microglial morphologies (red arrows) observed within the injury-only lesion site at 4, 7 and 14 DPL, respectively. (<b>F</b>–<b>H</b>) demonstrate microglia with a less reactive microglial phenotype and branched morphology within the DG implant at 4, 7 and 14 DPL, respectively. Orange arrows indicate branched ramified-like microglia. (<b>I</b>) Ramified ‘resting’ microglial morphology in control uninjured bOSCs at 18 DIV. Inset shows high magnification of ramified phenotypes. (<b>J</b>) Graph shows that microglial numbers reduce after 7 DPL in injury-alone slices without biomaterial implantation. With biomaterial implantation, a dramatic increase in microglial infiltration is observed. (<b>K</b>) Morphological analysis of microglial phenotypes shows that cells within the DG implant are significantly more ramified than microglial cells within the lesion alone (data presented as mean ± SEM and analysed by a two-way ANOVA with Tukey’s multiple comparisons, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, <span class="html-italic">n</span> = 3).</p>
Full article ">
10 pages, 2403 KiB  
Article
The Effect of Bilateral, Two-Level Cervical Sympathetic Chain Blocks on Specific Symptom Clusters for Traumatic Brain Injury, Independent of Concomitant PTSD Symptoms
by Sean W. Mulvaney, James H. Lynch, Sanjay Mahadevan, Kyle J. Dineen and Kristine L. Rae Olmsted
Brain Sci. 2024, 14(12), 1193; https://doi.org/10.3390/brainsci14121193 - 27 Nov 2024
Viewed by 752
Abstract
Background/Objectives: The aim of this study was to determine if performing ultrasound-guided, bilateral, two-level cervical sympathetic chain blocks (2LCSBs) (performed on subsequent days) improves symptoms associated with traumatic brain injury (TBI) that do not overlap with posttraumatic stress disorder (PTSD). Methods: [...] Read more.
Background/Objectives: The aim of this study was to determine if performing ultrasound-guided, bilateral, two-level cervical sympathetic chain blocks (2LCSBs) (performed on subsequent days) improves symptoms associated with traumatic brain injury (TBI) that do not overlap with posttraumatic stress disorder (PTSD). Methods: A retrospective chart review was conducted between August 2022 and February 2023. We identified twenty patients who received bilateral 2LCSBs for PTSD and anxiety symptoms and who also had a history of TBI. Neurobehavioral Symptom Inventory (NSI) scores were collected at baseline, one week, and one month post treatment in 13 males and 7 females. A sub-analysis of the first ten questions of the NSI, which we identified as not overlapping with PTSD or anxiety symptoms, generated an NSI sub-score. Results: Out of 20 patients, all showed improvement in their NSI scores and NSI sub-scores. The NSI sub-scores had a baseline average of 15.45 (on a 40-point scale); the average score at one week post treatment was 8.30; and that at one month post treatment was 7.80. This represents a 49.51% improvement in TBI symptoms which did not overlap with PTSD or anxiety symptoms between baseline and one month. Conclusions: The use of bilateral 2LCSBs may be helpful in treating patients with TBI, regardless of the presence of comorbid PTSD symptoms. Full article
(This article belongs to the Section Neurorehabilitation)
Show Figures

Figure 1

Figure 1
<p>Decrease in patient NSI scores following 2LCSB intervention at baseline, one week, and one month. Total scores decreased by nearly 50%, while male patients improved by nearly 10% more than female patients.</p>
Full article ">Figure 2
<p>Decrease in patient NSI sub-scores for TBI symptoms following 2LCSB intervention at baseline, one week, and one month. Total scores decreased by nearly 50%, while male patients improved by nearly 4% more than female patients.</p>
Full article ">Figure 3
<p>Decrease in patient PCL-5 scores for TBI symptoms following 2LCSB intervention at baseline, one week, and one month. Total scores decreased by over 50%, while female patients improved by nearly 7% more than male patients.</p>
Full article ">Figure 4
<p>Overlap between TBI and PTSD symptoms as derived from the NSI and PCL-5.</p>
Full article ">
Back to TopTop